ANI Pharmaceuticals Inc
Chiusa
SettoreSettore sanitario
82.22 -0.36
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
82.04
Massimo
83.9
Entrata | -61K 27M |
|---|---|
Vendite | -9.6M 237M |
P/E Media del settore | 20.609 50.958 |
EPS | 1.68 |
Margine di Profitto | 11.551 |
Dipendenti | 970 |
EBITDA | -20M 57M |
Raccomandazioni | Fortemente da comprare |
|---|---|
Previsioni per 12 mesi | +37.81% upside |
Utili prossimi | 7 ago 2026 |
|---|
Capitalizzazione di Mercato | -41M 1.8B |
|---|---|
Apertura precedente | 82.58 |
Chiusura precedente | 82.22 |
Notizie sul Sentiment di mercato
By Acuity
50%
50%
146 / 342 Classifica in Healthcare
ANI Pharmaceuticals Inc Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Chi Siamo ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.